Risk of HIV infection in studies of African women using hormonal contraceptives

Use of the injectable progestin contraceptive depot-medroxyprogesterone acetate (DMPA) is linked to an increased risk for HIV infection, according to a new article. The researchers did not find a significantly increased risk for HIV infection in women who used a different injectable progestin, norethisterone enanthate (NET-EN), nor in those who used combined oral contraceptives (COC).

Read the whole article on Science Daily

More from Science Daily